These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 31536833)

  • 1. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
    Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
    Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors.
    Broni E; Ashley C; Adams J; Manu H; Aikins E; Okom M; Miller WA; Wilson MD; Kwofie SK
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds.
    Darko LKS; Broni E; Amuzu DSY; Wilson MD; Parry CS; Kwofie SK
    Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola.
    Nasution MAF; Toepak EP; Alkaff AH; Tambunan USF
    BMC Bioinformatics; 2018 Nov; 19(Suppl 14):419. PubMed ID: 30453886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the therapeutic potential of galidesivir analogs against Zaire ebolavirus protein 24 (V24): database screening, molecular docking, drug-relevant property evaluation and molecular dynamics simulations.
    Hassan HA; Abdelwahab SF; Al-Khdhairawi A; Al Zrkani MK; Rehman HM; Abdel-Rahman IM; El-Sheikh AAK; Abdelhamid MM
    J Biomol Struct Dyn; 2024 Aug; 42(13):6761-6771. PubMed ID: 37477257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin.
    Kwofie SK; Broni E; Asiedu SO; Kwarko GB; Dankwa B; Enninful KS; Tiburu EK; Wilson MD
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33466743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin Blocks Ebola Virus Infection by Counteracting the VP24 Interferon-Inhibitory Function.
    Fanunza E; Iampietro M; Distinto S; Corona A; Quartu M; Maccioni E; Horvat B; Tramontano E
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40.
    Mirza MU; Ikram N
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
    Fanunza E; Frau A; Corona A; Tramontano E
    Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herbal Lead as Ideal Bioactive Compounds Against Probable Drug Targets of Ebola Virus in Comparison with Known Chemical Analogue: A Computational Drug Discovery Perspective.
    Setlur AS; Naik SY; Skariyachan S
    Interdiscip Sci; 2017 Jun; 9(2):254-277. PubMed ID: 26857866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids as Multi-target Inhibitors for Proteins Associated with Ebola Virus: In Silico Discovery Using Virtual Screening and Molecular Docking Studies.
    Raj U; Varadwaj PK
    Interdiscip Sci; 2016 Jun; 8(2):132-141. PubMed ID: 26286008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics and combined docking studies for the identification of Zaire ebola virus inhibitors.
    Sulaiman KO; Kolapo TU; Onawole AT; Islam MA; Adegoke RO; Badmus SO
    J Biomol Struct Dyn; 2019 Aug; 37(12):3029-3040. PubMed ID: 30058446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoinformatics-based identification of chemically active molecules against Ebola virus.
    Islam MA; Pillay TS
    J Biomol Struct Dyn; 2019 Sep; 37(15):4104-4119. PubMed ID: 30449258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An all-atom molecular dynamics study of the anti-interferon signaling of Ebola virus: interaction mechanisms of EBOV VP24 binding to Karyopherin alpha5.
    Ding JN; Zhang YJ; Zhong H; Ao CC; Li J; Han JG
    Mol Biosyst; 2017 May; 13(5):1031-1045. PubMed ID: 28418440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype.
    Vidal S; Sánchez-Aparicio M; Seoane R; El Motiam A; Nelson EV; Bouzaher YH; Baz-Martínez M; García-Dorival I; Gonzalo S; Vázquez E; Vidal A; Muñoz-Fontela C; García-Sastre A; Rivas C
    mBio; 2021 Aug; 12(4):e0097221. PubMed ID: 34225493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability.
    Schwarz TM; Edwards MR; Diederichs A; Alinger JB; Leung DW; Amarasinghe GK; Basler CF
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Integrity of the YxxL Motif of Ebola Virus VP24 Is Important for the Transport of Nucleocapsid-Like Structures and for the Regulation of Viral RNA Synthesis.
    Takamatsu Y; Kolesnikova L; Schauflinger M; Noda T; Becker S
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32102881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single phosphorodiamidate morpholino oligomer targeting VP24 protects rhesus monkeys against lethal Ebola virus infection.
    Warren TK; Whitehouse CA; Wells J; Welch L; Heald AE; Charleston JS; Sazani P; Reid SP; Iversen PL; Bavari S
    mBio; 2015 Feb; 6(1):. PubMed ID: 25670780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus.
    Karthick V; Nagasundaram N; Doss CG; Chakraborty C; Siva R; Lu A; Zhang G; Zhu H
    Infect Dis Poverty; 2016 Feb; 5():12. PubMed ID: 26888469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.
    Ilinykh PA; Lubaki NM; Widen SG; Renn LA; Theisen TC; Rabin RL; Wood TG; Bukreyev A
    J Virol; 2015 Aug; 89(15):7567-83. PubMed ID: 25972536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.